"/> Tocris Bioscience™ ASP 3026 | B-LABO France

Tocris Bioscience™ ASP 3026

Réf. : BL-RE-125348Réf. fabricant : 18701698 10 mg
170,62 € HT

Potent anaplastic lymphoma kinase (ALK) inhibitor; also potent ACK inhibitor

Nom chimique ou matériau
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
CAS
1097917-15-1
Quantité
10 mg
Cible
ALK Inhibitors
Formule moléculaire
C29H40N8O3S
Marque
Tocris Bioscience

ASP 3026 is a potent anaplastic lymphoma kinase (ALK) inhibitor (IC50 = 3.5 nM). Also inhibits Ack and ROS1 activity (IC50 values are 5.8 and 8.9 nM respectively). Attenuates proliferation, and induces apoptosis of NPM-ALK+ T cell anaplastic large-cell lymphoma (ALCL) cells

in vitro

. Suppresses tumor growth of NPM-ALK+ ALCL cell xenografts in mice. Causes tumor shrinkage in hEML4-ALK transgenic mice. Orally available.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-125348
Réf. fabricant18701698
Nom chimique ou matériauN2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
CAS1097917-15-1
Quantité10 mg
CibleALK Inhibitors
Formule moléculaireC<sub>29</sub>H<sub>40</sub>N<sub>8</sub>O<sub>3</sub>S
Poids de la formule580.74
Pureté>99%
Une question, une configuration particulière ?
Contactez-nous pour un devis.